Endoscopic Devices - Mexico | Statista Market Forecast

Revenue in the Endoscopic Devices market market in Mexico is anticipated to attain US$454.80m in 2024.
The revenue is forecasted to exhibit an annual growth rate (CAGR 2024-2029) of 6.95%, leading to a market volume of US$636.30m by 2029.
In a broader context, the majority of revenue is projected to be generated the United States, amounting to US$10.39bn in 2024.
The Mexican market for endoscopic devices is experiencing significant growth due to increasing healthcare investments and a rising demand for minimally invasive surgical procedures.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market in Mexico is witnessing moderate growth, influenced by factors such as advancements in minimally invasive procedures, increasing prevalence of gastrointestinal disorders, and a rising demand for innovative healthcare solutions among patients and providers.

Customer preferences: In Mexico, there is a growing preference for less invasive medical interventions, reflecting a cultural shift towards prioritizing recovery and quality of life. Patients increasingly favor endoscopic procedures due to their minimal recovery times and reduced discomfort compared to traditional surgeries. Additionally, as the population ages and lifestyle-related health issues rise, there is heightened awareness and demand for advanced endoscopic devices. This trend is further supported by healthcare providers seeking to enhance patient outcomes through innovative technologies and improved procedural efficiencies.

Trends in the market: In Mexico, the Endoscopic Devices Market is experiencing significant growth driven by an increasing demand for minimally invasive procedures, as patients prioritize swift recovery and reduced discomfort. The aging population, coupled with a rise in lifestyle-related health conditions, is propelling the adoption of advanced endoscopic technologies. Healthcare providers are investing in innovative devices to improve patient outcomes and procedural efficiency. This trend underscores the importance of aligning product development with patient preferences, presenting opportunities for manufacturers and stakeholders to enhance their market presence and cater to evolving healthcare needs.

Local special circumstances: In Mexico, the Endoscopic Devices Market is influenced by a combination of local healthcare policies and cultural attitudes towards medical procedures. The government’s investment in healthcare infrastructure aims to improve access and quality, thereby fostering the adoption of advanced endoscopic technologies. Additionally, cultural preferences for minimally invasive treatments align with the growing acceptance of these procedures, as families often prioritize swift recovery and minimal discomfort for their loved ones. This unique blend of regulatory support and cultural values drives market expansion and innovation within the sector.

Underlying macroeconomic factors: The Endoscopic Devices Market in Mexico is significantly shaped by macroeconomic factors such as national economic stability, healthcare investment, and demographic trends. As the Mexican economy continues to recover and grow, increased government spending on healthcare infrastructure enhances access to advanced medical technologies. Additionally, favorable fiscal policies that promote innovation in medical devices encourage local manufacturers and attract foreign investment. The rising prevalence of gastrointestinal diseases, coupled with an aging population, further drives the demand for endoscopic procedures. This combination of economic health and demographic changes fosters a robust environment for market expansion and technological advancements within the sector.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.